Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Röhrig UF, Majjigapu SR, Vogel P, Reynaud A, Pojer F, Dilek N, Reichenbach P, Ascenção K, Irving M, Coukos G, Michielin O, Zoete V.
Röhrig UF, et al. Among authors: ascencao k.
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1773-1811. doi: 10.1080/14756366.2022.2089665.
J Enzyme Inhib Med Chem. 2022.
PMID: 35758198
Free PMC article.